The prevalence of AG and IM in the world
Author (year) | Country | Diagnostic methods | Study population (n) | AG (%) antrum/body | IM (%) antrum/body |
---|---|---|---|---|---|
Kim et al. (2008)11 | Korea | Histology | 389 | 42.5/20.1 | 28.6/21.2 |
Kim et al. (2008)42 | Korea | Histology | 713 | 42.7/38.1 | 42.5/32.7 |
Park et al. (2012)43 | Korea | Endoscopy | 25,536 | 27.1 |
7.1 |
Joo et al. (2013)44 | Korea | Endoscopy | 4,023 | 40.7 |
12.5 |
Weck et al. (2007)45 | Germany | Serology |
9,444 | 6.0 |
- |
Borch et al. (2000)46 | Sweden | Histology | 501 | 9.4 |
- |
Asaka et al. (2001)47 | Japan | Histology | 2,455 | 55.5 |
24.2 |
Zou et al. (2011)48 | China | Histology | 1,022 | 63.8 |
- |
Eriksson et al. (2008)49 | Finland | Histology | 505 | - | 18.8/7.1 |
Almouradi et al. (2013)50 | USA | Histology | 437 | - | 15.0 |
AG, atrophic gastritis; IM, intestinal metaplasia.
Serology was test by
Prevalence of AG or IM in the antrum and/or body.